HEADER PROTEIN FIBRIL 28-JUN-16 5KO0 TITLE HUMAN ISLET AMYLOID POLYPEPTIDE SEGMENT 15-FLVHSSNNFGA-25 DETERMINED TITLE 2 BY MICROED COMPND MOL_ID: 1; COMPND 2 MOLECULE: HIAPP(15-25)WT; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: AMYLIN, DIABETES-ASSOCIATED PEPTIDE, DAP, INSULINOMA AMYLOID COMPND 5 PEPTIDE; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: ISLET AMYLOID SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606 KEYWDS AMYLOID, ISLET AMYLOID POLYPEPTIDE, TYPE II DIABETES, TOXIC SPINE, KEYWDS 2 MICROED, PROTEIN FIBRIL EXPDTA ELECTRON CRYSTALLOGRAPHY AUTHOR P.A.L.KROTEE,J.A.RODRIGUEZ,M.R.SAWAYA,D.CASCIO,D.SHI,B.L.NANNENGA, AUTHOR 2 J.HATTNE,F.E.REYES,T.GONEN,D.S.EISENBERG REVDAT 8 06-MAR-24 5KO0 1 REMARK REVDAT 7 30-JUN-21 5KO0 1 REMARK REVDAT 6 20-NOV-19 5KO0 1 REMARK REVDAT 5 04-SEP-19 5KO0 1 JRNL REVDAT 4 06-JUN-18 5KO0 1 REMARK REVDAT 3 25-APR-18 5KO0 1 REMARK REVDAT 2 13-SEP-17 5KO0 1 REMARK REVDAT 1 21-DEC-16 5KO0 0 JRNL AUTH P.KROTEE,J.A.RODRIGUEZ,M.R.SAWAYA,D.CASCIO,F.E.REYES,D.SHI, JRNL AUTH 2 J.HATTNE,B.L.NANNENGA,M.E.OSKARSSON,S.PHILIPP,S.GRINER, JRNL AUTH 3 L.JIANG,C.G.GLABE,G.T.WESTERMARK,T.GONEN,D.S.EISENBERG JRNL TITL ATOMIC STRUCTURES OF FIBRILLAR SEGMENTS OF HIAPP SUGGEST JRNL TITL 2 TIGHTLY MATED BETA-SHEETS ARE IMPORTANT FOR CYTOTOXICITY. JRNL REF ELIFE V. 6 2017 JRNL REFN ESSN 2050-084X JRNL PMID 28045370 JRNL DOI 10.7554/ELIFE.19273 REMARK 2 REMARK 2 RESOLUTION. 1.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 9.75 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 2.010 REMARK 3 COMPLETENESS FOR RANGE (%) : 75.6 REMARK 3 NUMBER OF REFLECTIONS : 2177 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.229 REMARK 3 R VALUE (WORKING SET) : 0.225 REMARK 3 FREE R VALUE : 0.259 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.010 REMARK 3 FREE R VALUE TEST SET COUNT : 218 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 9.7490 - 1.7605 0.82 1062 119 0.2152 0.2401 REMARK 3 2 1.7605 - 1.4000 0.69 897 99 0.2506 0.3155 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.210 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 29.830 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 7.76 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 9.03 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 176 REMARK 3 ANGLE : 1.216 235 REMARK 3 CHIRALITY : 0.047 24 REMARK 3 PLANARITY : 0.004 32 REMARK 3 DIHEDRAL : 12.170 52 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5KO0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-JUN-16. REMARK 100 THE DEPOSITION ID IS D_1000222506. REMARK 240 REMARK 240 EXPERIMENTAL DETAILS REMARK 240 RECONSTRUCTION METHOD : CRYSTALLOGRAPHY REMARK 240 SAMPLE TYPE : 3D ARRAY REMARK 240 SPECIMEN TYPE : NULL REMARK 240 DATA ACQUISITION REMARK 240 DATE OF DATA COLLECTION : 04-NOV-14 REMARK 240 TEMPERATURE (KELVIN) : 100.0 REMARK 240 PH : NULL REMARK 240 NUMBER OF CRYSTALS USED : NULL REMARK 240 MICROSCOPE MODEL : FEI TECNAI 20 REMARK 240 DETECTOR TYPE : TVIPS TEMCAM-F416 (4K X 4K) REMARK 240 ACCELERATION VOLTAGE (KV) : 200 REMARK 240 NUMBER OF UNIQUE REFLECTIONS : 2180 REMARK 240 RESOLUTION RANGE HIGH (A) : 1.400 REMARK 240 RESOLUTION RANGE LOW (A) : 17.733 REMARK 240 DATA SCALING SOFTWARE : XSCALE REMARK 240 COMPLETENESS FOR RANGE (%) : 75.0 REMARK 240 DATA REDUNDANCY : NULL REMARK 240 IN THE HIGHEST RESOLUTION SHELL REMARK 240 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) :1.40 REMARK 240 HIGHEST RESOLUTION SHELL, RANGE LOW (A) :1.44 REMARK 240 COMPLETENESS FOR SHELL (%) : 35.3 REMARK 240 DATA REDUNDANCY IN SHELL : NULL REMARK 240 R MERGE FOR SHELL (I) : 0.50500 REMARK 240 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 240 SOFTWARE USED : PHASER 2.5.6 REMARK 240 STARTING MODEL : NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL UNIT IS AN EXTENDED BETA SHEET COMPRISING REMARK 300 PEPTIDES REPEATED AD INFINITUM ALONG THE A CRYSTAL AXIS. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: OCTADECAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 -46.72000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 3 1.000000 0.000000 0.000000 -35.04000 REMARK 350 BIOMT2 3 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 4 1.000000 0.000000 0.000000 -23.36000 REMARK 350 BIOMT2 4 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 4 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 5 1.000000 0.000000 0.000000 -11.68000 REMARK 350 BIOMT2 5 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 5 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 6 1.000000 0.000000 0.000000 11.68000 REMARK 350 BIOMT2 6 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 6 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 7 1.000000 0.000000 0.000000 23.36000 REMARK 350 BIOMT2 7 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 7 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 8 1.000000 0.000000 0.000000 35.04000 REMARK 350 BIOMT2 8 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 8 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 9 1.000000 0.000000 0.000000 46.72000 REMARK 350 BIOMT2 9 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 9 0.000000 0.000000 1.000000 0.00000 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SCN B 101 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-8273 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-8272 RELATED DB: EMDB REMARK 900 RELATED ID: 5KNZ RELATED DB: PDB DBREF 5KO0 A 15 25 UNP P10997 IAPP_HUMAN 48 58 DBREF 5KO0 B 15 25 UNP P10997 IAPP_HUMAN 48 58 SEQRES 1 A 11 PHE LEU VAL HIS SER SER ASN ASN PHE GLY ALA SEQRES 1 B 11 PHE LEU VAL HIS SER SER ASN ASN PHE GLY ALA HET SCN B 101 3 HETNAM SCN THIOCYANATE ION FORMUL 3 SCN C N S 1- FORMUL 4 HOH *6(H2 O) SHEET 1 AA1 2 LEU A 16 GLY A 24 0 SHEET 2 AA1 2 LEU B 16 GLY B 24 -1 O VAL B 17 N PHE A 23 SITE 1 AC1 2 ASN A 22 SER B 19 CRYST1 11.680 18.180 19.930 62.84 88.90 87.60 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.085616 -0.003584 -0.000010 0.00000 SCALE2 0.000000 0.055054 -0.028217 0.00000 SCALE3 0.000000 0.000000 0.056392 0.00000 ATOM 1 N PHE A 15 6.228 -6.806 -8.952 1.00 13.92 N ATOM 2 CA PHE A 15 4.932 -6.630 -8.313 1.00 11.43 C ATOM 3 C PHE A 15 4.946 -5.440 -7.376 1.00 6.45 C ATOM 4 O PHE A 15 5.998 -5.044 -6.883 1.00 10.20 O ATOM 5 CB PHE A 15 4.531 -7.882 -7.526 1.00 11.60 C ATOM 6 CG PHE A 15 5.346 -8.097 -6.278 1.00 13.43 C ATOM 7 CD1 PHE A 15 4.925 -7.585 -5.059 1.00 17.62 C ATOM 8 CD2 PHE A 15 6.537 -8.799 -6.327 1.00 13.96 C ATOM 9 CE1 PHE A 15 5.675 -7.766 -3.921 1.00 8.36 C ATOM 10 CE2 PHE A 15 7.289 -8.988 -5.182 1.00 18.33 C ATOM 11 CZ PHE A 15 6.855 -8.474 -3.982 1.00 14.08 C ATOM 12 N LEU A 16 3.761 -4.879 -7.142 1.00 9.53 N ATOM 13 CA LEU A 16 3.560 -3.891 -6.090 1.00 8.17 C ATOM 14 C LEU A 16 2.379 -4.247 -5.236 1.00 6.69 C ATOM 15 O LEU A 16 1.278 -4.389 -5.742 1.00 10.98 O ATOM 16 CB LEU A 16 3.302 -2.511 -6.655 1.00 10.91 C ATOM 17 CG LEU A 16 3.328 -1.269 -5.767 1.00 11.03 C ATOM 18 CD1 LEU A 16 4.701 -1.049 -5.160 1.00 15.61 C ATOM 19 CD2 LEU A 16 2.905 -0.057 -6.587 1.00 17.06 C ATOM 20 N VAL A 17 2.587 -4.358 -3.936 1.00 5.28 N ATOM 21 CA VAL A 17 1.450 -4.442 -3.039 1.00 4.23 C ATOM 22 C VAL A 17 1.255 -3.028 -2.509 1.00 3.45 C ATOM 23 O VAL A 17 2.236 -2.335 -2.229 1.00 5.11 O ATOM 24 CB VAL A 17 1.682 -5.449 -1.903 1.00 7.10 C ATOM 25 CG1 VAL A 17 0.508 -5.487 -0.943 1.00 14.13 C ATOM 26 CG2 VAL A 17 1.959 -6.829 -2.484 1.00 6.68 C ATOM 27 N HIS A 18 0.011 -2.574 -2.391 1.00 4.46 N ATOM 28 CA HIS A 18 -0.224 -1.206 -1.954 1.00 6.38 C ATOM 29 C HIS A 18 -1.525 -1.124 -1.217 1.00 1.91 C ATOM 30 O HIS A 18 -2.426 -1.926 -1.441 1.00 3.20 O ATOM 31 CB HIS A 18 -0.261 -0.248 -3.135 1.00 3.54 C ATOM 32 CG HIS A 18 -1.265 -0.638 -4.167 1.00 10.19 C ATOM 33 ND1 HIS A 18 -2.588 -0.260 -4.095 1.00 10.38 N ATOM 34 CD2 HIS A 18 -1.155 -1.420 -5.267 1.00 13.18 C ATOM 35 CE1 HIS A 18 -3.245 -0.772 -5.120 1.00 14.15 C ATOM 36 NE2 HIS A 18 -2.399 -1.479 -5.846 1.00 15.29 N ATOM 37 N SER A 19 -1.620 -0.136 -0.345 1.00 2.35 N ATOM 38 CA SER A 19 -2.835 0.139 0.378 1.00 3.26 C ATOM 39 C SER A 19 -2.957 1.650 0.535 1.00 2.18 C ATOM 40 O SER A 19 -1.950 2.358 0.594 1.00 4.28 O ATOM 41 CB SER A 19 -2.823 -0.568 1.733 1.00 3.43 C ATOM 42 OG SER A 19 -1.799 -0.050 2.556 1.00 9.19 O ATOM 43 N SER A 20 -4.188 2.142 0.575 1.00 5.10 N ATOM 44 CA SER A 20 -4.445 3.550 0.842 1.00 3.90 C ATOM 45 C SER A 20 -5.680 3.664 1.720 1.00 3.11 C ATOM 46 O SER A 20 -6.550 2.799 1.684 1.00 4.08 O ATOM 47 CB SER A 20 -4.644 4.334 -0.454 1.00 11.53 C ATOM 48 OG SER A 20 -3.409 4.530 -1.113 1.00 16.31 O ATOM 49 N ASN A 21 -5.747 4.723 2.514 1.00 1.10 N ATOM 50 CA ASN A 21 -6.922 4.993 3.322 1.00 4.44 C ATOM 51 C ASN A 21 -7.107 6.499 3.451 1.00 2.47 C ATOM 52 O ASN A 21 -6.144 7.258 3.385 1.00 2.33 O ATOM 53 CB ASN A 21 -6.807 4.379 4.719 1.00 6.05 C ATOM 54 CG ASN A 21 -6.349 2.945 4.711 1.00 13.64 C ATOM 55 OD1 ASN A 21 -7.166 2.027 4.796 1.00 18.96 O ATOM 56 ND2 ASN A 21 -5.043 2.737 4.624 1.00 14.78 N ATOM 57 N ASN A 22 -8.345 6.935 3.618 1.00 4.09 N ATOM 58 CA ASN A 22 -8.587 8.312 3.991 1.00 7.10 C ATOM 59 C ASN A 22 -9.865 8.468 4.801 1.00 3.66 C ATOM 60 O ASN A 22 -10.734 7.596 4.829 1.00 4.58 O ATOM 61 CB ASN A 22 -8.613 9.223 2.757 1.00 8.06 C ATOM 62 CG ASN A 22 -9.787 8.962 1.858 1.00 9.67 C ATOM 63 OD1 ASN A 22 -10.915 9.343 2.168 1.00 10.31 O ATOM 64 ND2 ASN A 22 -9.533 8.324 0.723 1.00 16.48 N ATOM 65 N PHE A 23 -9.948 9.598 5.482 1.00 3.73 N ATOM 66 CA PHE A 23 -11.062 9.902 6.360 1.00 4.71 C ATOM 67 C PHE A 23 -11.228 11.398 6.452 1.00 3.65 C ATOM 68 O PHE A 23 -10.247 12.126 6.600 1.00 5.46 O ATOM 69 CB PHE A 23 -10.845 9.317 7.757 1.00 9.78 C ATOM 70 CG PHE A 23 -11.827 9.814 8.773 1.00 10.53 C ATOM 71 CD1 PHE A 23 -13.141 9.404 8.729 1.00 11.64 C ATOM 72 CD2 PHE A 23 -11.441 10.700 9.767 1.00 14.41 C ATOM 73 CE1 PHE A 23 -14.052 9.864 9.657 1.00 12.17 C ATOM 74 CE2 PHE A 23 -12.365 11.171 10.701 1.00 10.59 C ATOM 75 CZ PHE A 23 -13.660 10.748 10.644 1.00 13.95 C ATOM 76 N GLY A 24 -12.466 11.867 6.378 1.00 4.34 N ATOM 77 CA GLY A 24 -12.697 13.295 6.439 1.00 9.11 C ATOM 78 C GLY A 24 -14.068 13.679 6.917 1.00 7.16 C ATOM 79 O GLY A 24 -14.981 12.851 6.983 1.00 5.56 O ATOM 80 N ALA A 25 -14.191 14.956 7.260 1.00 8.33 N ATOM 81 CA ALA A 25 -15.452 15.564 7.641 1.00 13.87 C ATOM 82 C ALA A 25 -15.363 17.081 7.498 1.00 21.48 C ATOM 83 O ALA A 25 -14.284 17.653 7.358 1.00 10.33 O ATOM 84 CB ALA A 25 -15.825 15.187 9.058 1.00 15.88 C ATOM 85 OXT ALA A 25 -16.375 17.777 7.515 1.00 21.98 O TER 86 ALA A 25 ATOM 87 N PHE B 15 -11.556 18.704 7.651 1.00 10.15 N ATOM 88 CA PHE B 15 -10.238 18.099 7.652 1.00 10.31 C ATOM 89 C PHE B 15 -10.214 16.927 6.692 1.00 9.13 C ATOM 90 O PHE B 15 -11.245 16.503 6.166 1.00 9.88 O ATOM 91 CB PHE B 15 -9.837 17.629 9.055 1.00 15.37 C ATOM 92 CG PHE B 15 -10.739 16.566 9.612 1.00 9.48 C ATOM 93 CD1 PHE B 15 -11.801 16.903 10.425 1.00 13.50 C ATOM 94 CD2 PHE B 15 -10.547 15.232 9.292 1.00 9.60 C ATOM 95 CE1 PHE B 15 -12.639 15.934 10.931 1.00 16.23 C ATOM 96 CE2 PHE B 15 -11.384 14.260 9.785 1.00 12.15 C ATOM 97 CZ PHE B 15 -12.426 14.610 10.611 1.00 17.31 C ATOM 98 N LEU B 16 -9.023 16.388 6.501 1.00 8.90 N ATOM 99 CA LEU B 16 -8.828 15.277 5.611 1.00 6.80 C ATOM 100 C LEU B 16 -7.577 14.530 6.023 1.00 9.11 C ATOM 101 O LEU B 16 -6.474 15.055 5.901 1.00 13.66 O ATOM 102 CB LEU B 16 -8.736 15.780 4.177 1.00 14.60 C ATOM 103 CG LEU B 16 -9.005 14.821 3.029 1.00 12.93 C ATOM 104 CD1 LEU B 16 -10.198 13.945 3.345 1.00 13.37 C ATOM 105 CD2 LEU B 16 -9.264 15.627 1.770 1.00 12.56 C ATOM 106 N VAL B 17 -7.747 13.319 6.543 1.00 3.24 N ATOM 107 CA VAL B 17 -6.617 12.493 6.947 1.00 6.08 C ATOM 108 C VAL B 17 -6.412 11.409 5.879 1.00 2.79 C ATOM 109 O VAL B 17 -7.370 10.912 5.289 1.00 2.55 O ATOM 110 CB VAL B 17 -6.835 11.848 8.341 1.00 4.87 C ATOM 111 CG1 VAL B 17 -5.545 11.270 8.845 1.00 8.98 C ATOM 112 CG2 VAL B 17 -7.310 12.882 9.357 1.00 6.73 C ATOM 113 N HIS B 18 -5.164 11.070 5.589 1.00 5.69 N ATOM 114 CA HIS B 18 -4.883 10.067 4.562 1.00 3.94 C ATOM 115 C HIS B 18 -3.574 9.357 4.834 1.00 4.26 C ATOM 116 O HIS B 18 -2.669 9.922 5.447 1.00 3.45 O ATOM 117 CB HIS B 18 -4.815 10.699 3.183 1.00 4.85 C ATOM 118 CG HIS B 18 -3.722 11.703 3.049 1.00 9.77 C ATOM 119 ND1 HIS B 18 -2.549 11.437 2.379 1.00 14.52 N ATOM 120 CD2 HIS B 18 -3.613 12.967 3.518 1.00 14.89 C ATOM 121 CE1 HIS B 18 -1.767 12.500 2.432 1.00 11.60 C ATOM 122 NE2 HIS B 18 -2.389 13.442 3.118 1.00 12.20 N ATOM 123 N SER B 19 -3.486 8.108 4.398 1.00 1.57 N ATOM 124 CA SER B 19 -2.223 7.394 4.437 1.00 5.87 C ATOM 125 C SER B 19 -2.149 6.325 3.375 1.00 2.51 C ATOM 126 O SER B 19 -3.153 5.843 2.860 1.00 3.69 O ATOM 127 CB SER B 19 -1.970 6.735 5.780 1.00 12.59 C ATOM 128 OG SER B 19 -2.476 5.419 5.791 1.00 15.28 O ATOM 129 N SER B 20 -0.923 5.936 3.078 1.00 3.51 N ATOM 130 CA SER B 20 -0.710 4.886 2.121 1.00 5.22 C ATOM 131 C SER B 20 0.574 4.144 2.456 1.00 2.14 C ATOM 132 O SER B 20 1.468 4.676 3.122 1.00 2.10 O ATOM 133 CB SER B 20 -0.669 5.458 0.701 1.00 8.58 C ATOM 134 OG SER B 20 0.387 6.381 0.541 1.00 15.03 O ATOM 135 N ASN B 21 0.633 2.896 2.026 1.00 2.41 N ATOM 136 CA ASN B 21 1.802 2.059 2.191 1.00 3.66 C ATOM 137 C ASN B 21 1.973 1.284 0.917 1.00 3.41 C ATOM 138 O ASN B 21 0.997 0.946 0.270 1.00 4.56 O ATOM 139 CB ASN B 21 1.637 1.101 3.361 1.00 11.64 C ATOM 140 CG ASN B 21 1.145 1.787 4.611 1.00 11.31 C ATOM 141 OD1 ASN B 21 0.002 1.600 5.020 1.00 18.14 O ATOM 142 ND2 ASN B 21 2.016 2.575 5.239 1.00 9.13 N ATOM 143 N ASN B 22 3.203 0.970 0.556 1.00 1.73 N ATOM 144 CA ASN B 22 3.391 0.019 -0.507 1.00 2.26 C ATOM 145 C ASN B 22 4.731 -0.650 -0.362 1.00 3.01 C ATOM 146 O ASN B 22 5.616 -0.151 0.334 1.00 2.93 O ATOM 147 CB ASN B 22 3.245 0.685 -1.872 1.00 7.99 C ATOM 148 CG ASN B 22 4.226 1.799 -2.088 1.00 8.43 C ATOM 149 OD1 ASN B 22 3.881 2.974 -1.981 1.00 17.19 O ATOM 150 ND2 ASN B 22 5.455 1.445 -2.421 1.00 13.41 N ATOM 151 N PHE B 23 4.852 -1.817 -0.973 1.00 3.37 N ATOM 152 CA PHE B 23 6.150 -2.411 -1.150 1.00 3.19 C ATOM 153 C PHE B 23 6.149 -3.132 -2.471 1.00 2.63 C ATOM 154 O PHE B 23 5.096 -3.460 -3.020 1.00 5.68 O ATOM 155 CB PHE B 23 6.535 -3.355 0.008 1.00 8.34 C ATOM 156 CG PHE B 23 5.770 -4.656 0.042 1.00 11.99 C ATOM 157 CD1 PHE B 23 6.253 -5.786 -0.613 1.00 9.99 C ATOM 158 CD2 PHE B 23 4.591 -4.758 0.762 1.00 12.38 C ATOM 159 CE1 PHE B 23 5.556 -6.980 -0.573 1.00 12.60 C ATOM 160 CE2 PHE B 23 3.883 -5.944 0.804 1.00 14.52 C ATOM 161 CZ PHE B 23 4.369 -7.056 0.140 1.00 12.82 C ATOM 162 N GLY B 24 7.339 -3.356 -2.997 1.00 3.14 N ATOM 163 CA GLY B 24 7.452 -4.130 -4.217 1.00 4.90 C ATOM 164 C GLY B 24 8.839 -4.671 -4.424 1.00 5.67 C ATOM 165 O GLY B 24 9.753 -4.391 -3.652 1.00 3.97 O ATOM 166 N ALA B 25 8.959 -5.491 -5.467 1.00 7.68 N ATOM 167 CA ALA B 25 10.232 -5.974 -5.984 1.00 6.17 C ATOM 168 C ALA B 25 10.064 -6.456 -7.419 1.00 13.87 C ATOM 169 O ALA B 25 8.948 -6.581 -7.923 1.00 13.92 O ATOM 170 CB ALA B 25 10.797 -7.090 -5.105 1.00 5.14 C ATOM 171 OXT ALA B 25 11.042 -6.713 -8.120 1.00 12.43 O TER 172 ALA B 25 HETATM 173 S SCN B 101 -7.246 7.684 7.225 1.00 19.29 S HETATM 174 C SCN B 101 -5.643 7.082 7.775 1.00 13.65 C HETATM 175 N SCN B 101 -4.579 6.683 8.109 1.00 20.06 N HETATM 176 O HOH A 101 -18.396 18.327 6.534 1.00 12.95 O HETATM 177 O HOH A 102 -3.537 1.897 -2.962 1.00 11.85 O HETATM 178 O HOH B 201 -1.807 9.308 1.677 1.00 10.52 O HETATM 179 O HOH B 202 13.443 -5.871 -8.944 1.00 8.46 O HETATM 180 O HOH B 203 5.252 -0.050 3.032 1.00 12.87 O HETATM 181 O HOH B 204 -4.644 16.045 3.680 1.00 14.49 O CONECT 173 174 CONECT 174 173 175 CONECT 175 174 MASTER 192 0 1 0 2 0 1 6 179 2 3 2 END